iShares Neuroscience and Healthcare ETF (IBRN)
NYSEARCA: IBRN · Real-Time Price · USD
37.69
-0.08 (-0.21%)
Jul 24, 2026, 4:00 PM EDT - Market closed
IBRN Holdings Information
IBRN is an equity ETF with a total of 79 individual holdings. The top holdings are Dianthus Therapeutics stock at 5.06%, Praxis Precision Medicines at 4.93%, Xenon Pharmaceuticals at 4.92%, Alkermes at 4.81%, and Arrowhead Pharmaceuticals at 4.61%.
Total Holdings
79
Top 10 Percentage
45.49%
Asset Class
Equity
ETF Category
Health
Assets
5.68M
PE Ratio
16.48
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | DNTH | Dianthus Therapeutics, Inc. | 5.06% |
| 2 | PRAX | Praxis Precision Medicines, Inc. | 4.93% |
| 3 | XENE | Xenon Pharmaceuticals Inc. | 4.92% |
| 4 | ALKS | Alkermes plc | 4.81% |
| 5 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.61% |
| 6 | ACAD | ACADIA Pharmaceuticals Inc. | 4.35% |
| 7 | SRRK | Scholar Rock Holding Corporation | 4.34% |
| 8 | PTCT | PTC Therapeutics, Inc. | 4.30% |
| 9 | NBIX | Neurocrine Biosciences, Inc. | 4.13% |
| 10 | ARGX | argenx SE | 4.04% |
| 11 | AXSM | Axsome Therapeutics, Inc. | 4.04% |
| 12 | BIIB | Biogen Inc. | 3.99% |
| 13 | DNLI | Denali Therapeutics Inc. | 3.61% |
| 14 | DYN | Dyne Therapeutics, Inc. | 3.27% |
| 15 | EWTX | Edgewise Therapeutics, Inc. | 3.20% |
| 16 | SUPN | Supernus Pharmaceuticals, Inc. | 2.66% |
| 17 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 2.20% |
| 18 | AXGN | Axogen, Inc. | 2.13% |
| 19 | BHVN | Biohaven Ltd. | 1.90% |
| 20 | HLUNB.CO | H. LUNDBECK CLASS B | 1.79% |
| 21 | SRPT | Sarepta Therapeutics, Inc. | 1.67% |
| 22 | TSHA | Taysha Gene Therapies, Inc. | 1.44% |
| 23 | STO: BIOA.B | BioArctic AB (publ) | 1.39% |
| 24 | SWX: IDIA | Idorsia Ltd | 1.37% |
| 25 | ASX: NEU | Neuren Pharmaceuticals Limited | 1.30% |
As of Jul 23, 2026